Closed tobiasko closed 4 months ago
Hi @tobiasko - indeed, this should be what is currently done:
> sce <- importDIANN(inFile = system.file("extdata/diann_example/PXD028735.report.tsv", package = "einprot"),
fileType = "main_report", outLevel = "pg", aName = "PG.Quantity")$sce
> SummarizedExperiment::assayNames(sce)
[1] "PG.Quantity" "PG.Normalised" "PG.MaxLFQ" "PG.Q.Value" "Global.PG.Q.Value"
[6] "Lib.PG.Q.Value" "Protein.Ids"
Ahhhh nice! So aName
is just a selector for the assay that is used for the statistical test, but all assay for a level are imported?
Yes, exactly - einprot
just needs to know where to start from when doing log-transformation, imputation, normalization and downstream analysis. But the other assays are exported as well.
What is the Protein.Ids
assay?
That one contains the protein IDs assigned to a protein group - einprot
detected that the values in this column are sometimes different for different samples (for the same protein group), and thus this information could not be added as a single annotation column. In this case, einprot
will report it as an assay instead (in this case, a matrix with character entries). For example:
> assay(sce, "Protein.Ids")[c(1, 6, 23), ]
LFQ_Orbitrap_AIF_Condition_A_Sample_Beta_01 LFQ_Orbitrap_AIF_Condition_B_Sample_Alpha_01
G5EA36;I3L328 "0" "0"
O94826 "O94826" "O94826"
P31948 "P31948;H0YGI8;F5GXD8;F5H783" "P31948;F5GXD8;F5H783"
LFQ_Orbitrap_AIF_Condition_A_Sample_Gamma_01 LFQ_Orbitrap_AIF_Condition_B_Sample_Beta_01
G5EA36;I3L328 "G5EA36;I3L328" "0"
O94826 "O94826" "O94826"
P31948 "P31948;H0YGI8;F5GXD8;F5H783" "P31948;H0YGI8;F5GXD8;F5H783"
LFQ_Orbitrap_AIF_Condition_B_Sample_Gamma_01
G5EA36;I3L328 "G5EA36;I3L328"
O94826 "O94826"
P31948 "P31948;H0YGI8;F5GXD8;F5H783"
LFQ_Orbitrap_AIF_Condition_A_Sample_Alpha_01
G5EA36;I3L328 "G5EA36;I3L328"
O94826 "O94826"
P31948 "P31948;H0YGI8;F5GXD8;F5H783"
🧐 The protein IDs assigned to a protein group are NOT the same across all analysed samples? I really wonder why DIA-NN does this and what it could mean!?
Good question :) that I have not yet found the answer to. I was thinking that perhaps in the second sample there was no evidence for H0YGI8
being present, and thus it did not contribute to the third protein group above in that sample.
I think the original question here was addressed, so I'll close the issue - feel free to reopen or open a new issue if there are additional questions!
Dear einprot developers,
a typical DIA-NN main report contains multiple abundance estimators for different feature levels. The packge example data shows:
So the protein group (PG.) and gene level (Genes.) is estimated by Quantity, Normalised (quantity), MaxLFQ and maxLFQ using only unique chromatographic features. So on the PG level one would have already 3 assays available for SE container import. All would reference the same set of features, so this should totally fit to the container definition
https://bioconductor.org/packages/release/bioc/vignettes/SummarizedExperiment/inst/doc/SummarizedExperiment.html
Have you thought about something like this instead of reducing to a single assay when building the container?